Ohio Medical Marijuana Control Program Releases Testing Laboratory Provisional License Application Materials

OHIO:The Ohio Medical Marijuana Control Program (MMCP) is scheduled to accept new testing laboratory license applications beginning the week of August 3, 2020. On its testing laboratories webpage, the MMCP has posted two documents for potential applicants to assist in understanding the key substantive attributes of the application.

Potential applicants may submit questions regarding the application materials using instructions listed on the testing laboratories webpage. All questions must be submitted by July 31, 2020. The MMCP will then provide the frequently asked questions and MMCP answers to potential applicants.

For more information, visit the MMCP’s testing laboratories webpage.

Casa Verde Capital Leads Investment In Cannabis Testing Lab Cannalysis

Snoop Dogg Venture Firm Helps Analytical Cannabis Laboratory Expand Its Nationwide Footprint

CALIFORNIA: Cannalysis, a cannabis testing laboratory, announced today a seed investment led by Casa Verde Capital. As the premier cannabis testing lab in the market, Cannalysis harnesses technology to provide best-in-class service to some of the largest cultivators and brands in California.

With California’s adult-use regulations coming into effect next year, government-mandated third party testing will create a huge demand for services. However, many existing labs are not prepared to deal with this type of volume due to inferior technology, creating significant bottlenecks in getting clean product to market. As such, Cannalysis is poised to fill this gap, with industry leading, guaranteed three business-day turnarounds.

Having built a custom platform from the ground up, Cannalysis streamlines the testing experience and puts all data in the client’s hands, providing real-time tracking and sample status updates. Furthermore, beautiful and intuitive reporting enables Cannalysis to deliver the story behind the test results, something that customers genuinely appreciate.

In that vein, Kurvana, one of the largest cannabis brands in California had this to say on its relationship with Cannalysis. “They push our high volumes of samples through analysis without impact to quality or turnaround time, and they are willing to work with us to prioritize the results we need most. Placing value in collaboration and transparency, Cannalysis has exceeded our expectations and raised our standards.”

“With a tech-first approach, Cannalysis has quickly established itself as one of the leading lab platforms in California. This approach has also positioned Cannalysis to quickly scale and establish JV partners around the country,” said Karan Wadhera, managing partner at Casa Verde Capital. Mr. Wadhera continued, “in fact, the first Cannalysis JV will come online in Portland early next year and we’re eager to secure new partnerships across the country to help extend the Cannalysis brand.”

Brian Lannon, CEO of Cannalysis, echoed these remarks, saying “we are at an inflection point for this industry and we are ready to expand. Having a marquee investor and strategic partner like Casa Verde, will be instrumental in helping us achieve our growth objectives.”

Steep Hill Hawaii Announces ISO Certification For First Licensed Cannabis Testing Lab In Hawaii

HAWAII: Dana Ciccone, CEO of Steep Hill Hawaii, the first state-licensed cannabis testing lab in Hawaii, announced it received ISO/IEC 17025:2005 certification by Perry Johnson Laboratory Accreditation Inc., an international accrediting agency recognized by governments and industry participants around the world as the standard of excellence for the operation of a quality laboratory management system.

Ciccone said in making the announcement on the achievement of the Certificate of Accreditation, “We are proud not only to be the first cannabis lab to be licensed in the State of Hawaii, but also now the first lab to achieve ISO certification, as well. Industry businesses, medical professionals, state regulators, and patients can be confident that our lab and its testing standards will operate to the highest international standards. This is a turning point for the industry – we have moved very quickly to raise the industry standards in Hawaii to internationally recognized certification. I am very proud of our scientific team’s professionalism and hard work to achieve this certification.”

Steep Hill Hawaii will run full-service testing for cannabinoid profiles (potency), terpenes, pesticides, heavy metals, biological screening, and residual solvents, testing for 17 cannabinoids and 43 terpenes. The company will test for industry businesses and in-state patient cardholders, and it has been structured to provide services to be affordable, with quick turn-around times. Steep Hill Hawaii is a locally owned and operated company.

 

Lightscale Labs Announces Cannabis Pesticide Testing In Oregon

OREGON: Lightscale Labs has joined a short list of accredited laboratories in Oregon how offering the full suite of compliance testing required for recreational and medical cannabis products.

“Pesticide testing is a critical component of making cannabis safer for Oregonians,” said Justin Ouellette, CEO of Lightscale Labs. “Cannabis producers and consumers alike have spoken loudly in favor of rigorous safety standards, but achieving those standards is a complex process and it’s meant that lab testing has generally fallen behind the incredible pace of the industry as a whole. We’re now starting to catch up.”

Oregon is unique among states that have legalized cannabis for its focus on health and safety. To receive a license to test cannabis, a laboratory must be accredited by the Oregon Health Authority (OHA) and undergo the same scrutiny as environmental labs that traditionally offer food, water, and soil testing. The accreditation process can be lengthy, creating a bottleneck for cannabis production in the state. With its new pesticide testing services, Lightscale Labs has significantly improved that bottleneck.

Recently, the OHA considered relaxing certain testing standards. “It’s important to find the right balance,” said Ouellette. “We all want to see the cannabis industry grow healthy and strong, and that means keeping lab testing requirements realistic. We hope Oregon will continue to serve as a model for the rest of the country, prioritizing public safety and evaluating the rules as the industry evolves and our scientific understanding improves.”

AACC Annual Scientific Meeting Focuses On The Latest Research on Cannabis Use and Testing

PENNSYLVANIA: At the 68th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 31–August 4 in Philadelphia, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore the latest research on cannabis use.

As legal recreational and medical marijuana use gains traction, it is critical that law enforcement have a way to test for whether someone is driving under the influence. However, recent research has revealed that determining whether a driver is impaired by marijuana is much more complicated than testing for blood alcohol content. In a plenary session, Marilyn A. Huestis, PhD, of the National Institute on Drug Abuse, will present the latest findings on the impact of cannabis use on driving and overall health, as well as the newest developments in testing for cannabinoids in blood and saliva.

Researchers from Calgary Laboratory Services in Canada will also present a study on a new urine test to detect cannabis and its metabolites that is accurate and cost-effective.

Budding Business: Pot Testing Lab Growing In Bend

OREGON:  Cascadia Labs is nestled amid ornamental fruit trees in a quiet office park on the north end of Bend. In this lab, employees with backgrounds in the biotechnology and pharmaceutical industries spend their days testing a variety of products with one common ingredient, consumed by thousands of patients across Oregon: medical marijuana.

Cascadia Labs co-owner Jeremy Sackett, 32, is just one of the entrepreneurs who has joined Oregon’s medical pot industry, where new regulations aimed at increasing quality and safety have helped spawn businesses headed up by people with backgrounds in science and the legal profession. Sackett worked at biotechnology companies until a year ago, when he started Cascadia Labs LLC with his wife, Ashley Preece-Sackett, 34. The company now has customers across the state who send samples via a medical courier service. The couple recently opened an office in Portland to receive samples, and Sackett is building a lab in Portland, too.

It is a sign of how quickly the medical marijuana landscape is changing in Oregon that Cascadia Labs is expanding at the same time Sackett is helping to draft a law that would grant the state authority to regulate these labs. New regulations on medical marijuana, passed by the Legislature in 2013 and implemented this year, are supposed to provide patients with safe access to cannabis products. But a state official involved with the program said the lack of regulatory authority over labs in the law prevents the state from ensuring medical pot is safe.

Tom Burns, director of pharmacy programs for the Oregon Health Authority, said that the state’s lack of authority to regulate pot testing labs essentially means that no one is testing the labs that test medical pot.